Top

Published in:

Open Access 01-02-2009 | Original

GERD prevalence in migraine patients and the implication for acute migraine treatment

Authors: Božena J. Katić, Wendy Golden, Roger K. Cady, X. Henry Hu

Published in: The Journal of Headache and Pain | Issue 1/2009

Abstract

The objective of this study is to estimate the prevalence of gastroesophageal reflux disease (GERD) and heartburn in migraine patients and examine their use of non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin-containing medications when treating acute migraine attacks. Responses from a web-based survey of migraine patients were matched to the same patient’s responses on a general health survey. A total of 1,832 migraineurs (92.0%) were successfully matched. A total of 403 migraineurs (22.0%) reported having diagnosed GERD, 212 (11.6%) reported diagnosed heartburn, and 290 (15.8%) reported reflux symptoms but were undiagnosed. The most common prescription drugs used to treat migraines were triptans. First-line NSAID/aspirin medication use was 10.0% among diagnosed GERD and heartburn patients, 17.8% among undiagnosed patients, and 11.8% among GERD/heartburn-free migraineurs. In conclusion, almost half of migraineurs reported physician-diagnosed GERD and heartburn or symptoms of these conditions. Use of NSAID medications for migraine is fairly common among diagnosed GERD patients and more so for those with undiagnosed GERD symptoms. Physicians should minimize prescribing NSAIDs or NSAID-containing acute migraine medications in this population.

Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2006) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache J Head Face Pain 47(3):355–363

Cady RK (1999) Diagnosis and treatment of migraine. Clin Cornerstone 1(6):21–32, 10682185, 10.1016/S1098-3597(99)90037-6, 1:STN:280:DC%2BD3c7ks1OltA%3D%3DCrossRefPubMed

Bigal ME, Lipton RB, Stewart WF (2004) The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 4(2):98–104, 14984680, 10.1007/s11910-004-0022-8CrossRefPubMed

Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 68(21):1851–1861, 17515549, 10.1212/01.wnl.0000262045.11646.b1CrossRefPubMed

Kurth T (2007) Associations between migraine and cardiovascular disease. Expert Rev Neurother 7(9):1097–1104, 17868009, 10.1586/14737175.7.9.1097CrossRefPubMed

Sevillano-Garcia MD, Manso-Calderon R, Cacabelos-Perez P (2007) Comorbidity in the migraine: depression, anxiety, stress and insomnia. Rev Neurol 45(7):400–405, 17918105, 1:STN:280:DC%2BD2srpsFyrtA%3D%3DPubMed

Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N (1997) Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54(4):362–368, 9109736, 1:STN:280:DyaK2s3mtlyltg%3D%3DCrossRefPubMed

Jones R, Lydeard S (1992) Irritable bowel syndrome in the general population. BMJ 304(6819):87–90, 1737146, 1:STN:280:DyaK387ksFWqtA%3D%3DPubMedCentralCrossRefPubMed

Merikangas KR, Fenton BT (1994) Comorbidity of migraine with somatic disorders in a large-scale epidemiologic study in the United States (47):301–314

10.

Aamodt AH, Stovner LJ, Hagen K, Zwart JA (2008) Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 28(2):144–151, 18197884, 1:STN:280:DC%2BD1c%2FksVaqtQ%3D%3DPubMed

11.

Featherstone HJ (1985) Medical diagnoses and problems in individuals with recurrent idiopathic headaches. Headache 25(3):136–140, 10.1111/j.1526-4610.1985.hed2503136.x, 1:STN:280:DyaL2M3jtlylsg%3D%3DCrossRef

12.

Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112(5):1448–1456, 9136821, 10.1016/S0016-5085(97)70025-8CrossRefPubMed

13.

Gutthann SP, Guez LA, Raiford DS (1997) Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 8(1):18–24, 9116088, 10.1097/00001648-199701000-00003, 1:STN:280:DyaK2s7jtVKnug%3D%3DCrossRefPubMed

14.

Ng-Mak DS, Hu XH, Chen YT, Ma L (2008) Acute migraine treatment with oral triptans and NSAIDS in a managed care population. Headache 48(8):1176–1185, 18819177, 10.1111/j.1526-4610.2007.01055.xCrossRefPubMed

15.

Kotzan J, Wade W, Yu HH (2001) Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 18(9):1367–1372, 11683254, 10.1023/A:1013010616496, 1:CAS:528:DC%2BD3MXnvVehurc%3DCrossRefPubMed

16.

Thomas J, Straus WL, Bloom BS (2002) Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am J Gastroenterol 97(9):2215–2219, 12358235, 10.1111/j.1572-0241.2002.05974.x, 1:CAS:528:DC%2BD38XotV2lu7s%3DCrossRefPubMed

17.

Hsu JC (2007) Hochberg’s step-up method: cutting corners off Holm’s step-down method. Biometrika 94(4):965–975, 10.1093/biomet/asm067CrossRef

18.

Dent J, El Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut J Br Soc Gastroenterol 54(5):710–717, 1:STN:280:DC%2BD2M7pslylsA%3D%3D

19.

Shaheen N, Provenzale D (2003) The epidemiology of gastroesophageal reflux disease. Am J Med Sci 326(5):264–273, 14615667, 10.1097/00000441-200311000-00002CrossRefPubMed

20.

DiBaise JK, Olusola BF, Huerter JV, Quigley EM (2002) Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. Am J Gastroenterol 97(4):843–850, 12003417, 10.1111/j.1572-0241.2002.05598.xCrossRefPubMed

21.

Pucci E, Di Stefano M, Miceli E, Corazza GR, Sandrini G, Nappi G (2005) Patients with headache and functional dyspepsia present meal-induced hypersensitivity of the stomach. J Headache Pain 6(4):223–226, 16362670, 10.1007/s10194-005-0191-0PubMedCentralCrossRefPubMed

22.

Spierings EL (2002) Reflux-triggered migraine headache originating from the upper gum/teeth. Cephalalgia 22(7):555–556, 12230598, 10.1046/j.1468-2982.2002.00373.x, 1:STN:280:DC%2BD38vovFektw%3D%3DCrossRefPubMed

23.

Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache J Head Face Pain 44(1):53–64, 10.1111/j.1526-4610.2004.04011.xCrossRef

24.

Karamanolis G, Sifrim D (2007) Developments in pathogenesis and diagnosis of gastroesophageal reflux disease. Curr Opin Gastroenterol 23(4):428–433, 17545781, 10.1097/MOG.0b013e328133f56aCrossRefPubMed

25.

Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8(4):801–815, 2175382, 1:STN:280:DyaK3M%2FotVOqsQ%3D%3DPubMed

26.

Kurth T, Holtmann G, Neufang-Hnber J, Gerken G, Diener HC (2006) Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia 26(5):506–510, 16674758, 10.1111/j.1468-2982.2005.01076.x, 1:STN:280:DC%2BD283ltVCltw%3D%3DCrossRefPubMed

27.

Edvinsson L (2005) Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. Cns Drug Rev 11(1):69–76, 15867953, 1:CAS:528:DC%2BD2MXks1Wls7w%3DCrossRefPubMed

28.

Arakawa T, Uno H, Fukuda T, Higuchi K, Kobayashi K, Kuroki T (1997) New aspects of gastric adaptive relaxation, reflex after food intake for more food: involvement of capsaicin-sensitive sensory nerves and nitric oxide. J Smooth Muscle Res 33(3):81–88, 9533819, 1:CAS:528:DyaK1cXktVSrtLw%3DCrossRefPubMed

29.

Meucci G, Radaelli F, Prada A, Bortoli A, Crotta S, Cerrato C, Minoli G (2005) Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open-access upper gastrointestinal endoscopy. Endoscopy 37(7):622–625, 16010605, 10.1055/s-2005-870251, 1:STN:280:DC%2BD2MzlsFKmsw%3D%3DCrossRefPubMed

30.

Horowitz M, Su YC, Rayner CK, Jones KL (2001) Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 15(12):805–813, 11773947, 1:STN:280:DC%2BD38%2FltVGlsw%3D%3DPubMed

31.

Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D (2006) Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache J Head Face Pain 46(1):57–63, 10.1111/j.1526-4610.2006.00311.xCrossRef

32.

Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102(4 Pt 1):1259–1268, 1551533, 1:STN:280:DyaK383gtFGltg%3D%3DPubMed

33.

Laine L (2002) The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 32(3):25–32, 12528071, 10.1053/sarh.2002.37217, 1:CAS:528:DC%2BD3sXot1Sjug%3D%3DCrossRefPubMed

34.

Voutilainen M, Sipponen P, Mecklin JP, Juhola M (2000) Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1, 128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 61(1):6–13, 10671769, 10.1159/000007730, 1:STN:280:DC%2BD3c7jsl2ksg%3D%3DCrossRefPubMed

35.

Bigard MA, Pelletier AL (2004) Esophageal complications of non steroidal antiinflammatory drugs. Gastroenterol Clin Biol 28:358–361, 10.1016/S0399-8320(04)95279-7CrossRef

36.

Kim SL, Hunter JG, Wo JM, Davis LP, Waring JP (1999) NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus? J Clin Gastroenterol 29(1):32–34, 10405227, 10.1097/00004836-199907000-00008, 1:STN:280:DyaK1Mzjt1Wgug%3D%3DCrossRefPubMed

37.

Dodick DW, Martin VT, Smith T, Silberstein S (2004) Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 44(s1):S20–S30

38.

Mulleners WM, Aurora SK, Chronicle EP, Stewart R, Gopal S, Koehler PJ (2001) Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately. Headache J Head Face Pain 41(1):31–39, 10.1046/j.1526-4610.2001.111006031.x, 1:STN:280:DC%2BD3Mzit1WisA%3D%3DCrossRef

39.

Iversen L, Hannaford PC, Godden DJ, Price D (2007) Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability. Prim Care Resp J 16(3):162–168, 10.3132/pcrj.2007.00013

40.

Tseeng S, Arora R (2008) Aspirin resistance: biological and clinical implications. J Cardiovasc Pharmacol Ther 13(1):5–12, 18287586, 10.1177/1074248407310869, 1:CAS:528:DC%2BD1cXjtVOhs7w%3DCrossRefPubMed

41.

Ducrotte P, Liker HR (2007) How do people with gastro-oesophageal reflux disease perceive their disease? Results of a multinational survey. Curr Med Res Opin 23(11):2857–2865, 17919358, 10.1185/030079907X233412CrossRefPubMed

42.

Malik SN, Hopkins M, Young WB, Silberstein SD (2006) Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache J Head Face Pain 46(5):773–780, 10.1111/j.1526-4610.2006.00437.xCrossRef

43.

Holmes WF, MacGregor EA, Sawyer JP, Lipton RB (2001) Information about migraine disability influences physicians’ perceptions of illness severity and treatment needs. Headache J Head Face Pain 41(4):343–350, 10.1046/j.1526-4610.2001.111006343.x, 1:STN:280:DC%2BD3M3jtFSjsw%3D%3DCrossRef

Title: GERD prevalence in migraine patients and the implication for acute migraine treatment
Authors: Božena J. Katić
Wendy Golden
Roger K. Cady
X. Henry Hu
Publication date: 01-02-2009
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2009
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-008-0083-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GERD prevalence in migraine patients and the implication for acute migraine treatment

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

CADASIL presenting as status migrainosus and persisting aura without infarction

Cardiac cephalgia

Botulinum toxin: could it be an effective treatment for chronic tension-type headache?

New policies to consolidate the journal’s hold on its latest position

Cluster headache associated with moyamoya

SUNCT syndrome responding absolutely to steroids in two cases with different etiologies